Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2026-01-03 @ 3:26 AM
Study NCT ID:
NCT00019695
Status:
TERMINATED
Last Update Posted:
2024-03-04
First Post:
2007-03-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | adenocarcinoma of the prostate | View |
| None | adult solid tumor | View |
| None | body system/site cancer | View |
| None | bone metastases | View |
| None | cancer | View |
| None | cellular diagnosis, prostate cancer | View |
| None | genetic condition | View |
| None | male reproductive cancer | View |
| None | metastatic cancer | View |
| None | prostate cancer | View |
| None | recurrent prostate cancer | View |
| None | site, metastatic cancer | View |
| None | solid tumor | View |
| None | stage IV prostate cancer | View |
| None | stage, prostate cancer | View |
| None | unclassified/other cancer | View |